Location: Yavne, Israel | Founded: 2018
Explore Bio I: Newly devised Bi-specific T-Cell engager with dramatically reduced toxicity, having long serum half-life, while maintaining improved tumor penetration.
Location: Yavne, Israel | Founded: 2018
Pantheon Bioscience develops groundbreaking molecular tools based on new anti-phage defense systems discovered by the Professor Rotem Sorek’s lab at the Weizmann Institute of Science. Understanding the mechanisms of action of these new systems will potentially result in disruptive tools for biotechnological applications.
Pantheon Bioscience will be set up in the M Ventures BioIncubator at Inter-Lab, Yavne Israel, profiting from knowledge,expertise and resources.
Scientific Founder
12+years of industrial and academic experience in multidisciplinary research and development of novel drugs in immuno-oncology, immunology and oncology. Biotech industry expert in the intersection of drug discovery, target validation and translation research.
Before joining Pantheon Bioscience Arthur served as a principal investigator at Hadassah Medical Center and for the past four years was the Head of Immuno-Oncology Research at Compugen.